[ET Net News Agency, 21 December 2023] KINTOR PHARMA-B (09939) rose 11% to HK$1.72,
breaking above the 10-D SMA of HK$1.713.
It hits an intra-day high of HK$1.74, and an intra-day low of HK$1.56. The total shares
traded was 6.04 million, with a value of HK$9.95m. The active buy/sell ratio is 62:38,
with net buying turnover of HK$2.37m. GOLDMAN SACHS (ASIA) SEC accounts for greatest net
responsive buying turnover of HK$128,416, with volume weighted average price of HK$1.636.
CHINA INNOVATION MARKET SER accounts for greatest net responsive selling turnover of
HK$1.29m, with volume weighted average price of HK$1.655. The stock has risen a combined
11.7% over the past 2 consecutive trading days.
Basic Information
=================
---------------------------------
Nominal 1.720 % Chg +10.97%
High 1.740 Low 1.560
Shares Tr 6.04m Turnover 9.95m
10-D SMA 1.713 %H.V 142.051
20-D SMA 1.916 VWAP 1.646
50-D SMA 2.510 RSI14 36.048
---------------------------------
Status: Breaking above the 10-D SMA, active buy/sell ratio is 62:38, with net buying
turnover of HK$2.37m, rising a combined 11.7% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
KINTOR PHARMA-B (09939) 1.72 +10.97
HUTCHMED (00013) 25.75 -5.16
INNOVENT BIO (01801) 39.15 -2.85
EVEREST MED-B (01952) 18.94 +1.39
KEYMED BIO-B (02162) 45.40 -3.61
WUXI BIO (02269) 28.25 -1.57
BEIGENE (06160) 103.90 -5.55
SCICLONE PHARMA (06600) 13.20 -5.71
ZAI LAB (09688) 20.95 -10.09
AKESO (09926) 42.75 -1.72
-----------------------------------------------
(ed)